Wird geladen...
GLP-1 Receptor Agonists: Nonglycemic Clinical Effects in Weight Loss and Beyond
OBECTIVE: Glucagon-like peptide-1 (GLP-1) receptor agonists are indicated for treatment of type 2 diabetes since they mimic the actions of native GLP-1 on pancreatic islet cells, stimulating insulin release, while inhibiting glucagon release, in a glucose-dependent manner. The observation of weight...
Gespeichert in:
| Veröffentlicht in: | Obesity (Silver Spring) |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Blackwell Publishing Ltd
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4692091/ https://ncbi.nlm.nih.gov/pubmed/25959380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/oby.21107 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|